Novavax, Inc. (NVAX)
9.36
+1.26
(+15.56%)
USD |
NASDAQ |
May 06, 16:00
9.37
+0.01
(+0.11%)
After-Hours: 06:03
Novavax Free Cash Flow : -97.62M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 14.12B |
| Pfizer Inc. | 9.484B |
| Moderna, Inc. | -1.603B |
| Johnson & Johnson | 17.80B |
| Intellia Therapeutics, Inc. | -395.86M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.42M |
| Cash from Investing (Quarterly) | -28.36M |
| Cash from Financing (Quarterly) | 37.68M |
| Free Cash Flow Per Share (Quarterly) | -0.2064 |
| Free Cash Flow to Equity (Quarterly) | -50.70M |
| Free Cash Flow to Firm (Quarterly) | -28.22M |
| Free Cash Flow Yield | -6.24% |